We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+31.44%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$719M
AUM Growth
-$27.1M
(-3.6%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-29.71%
Top 10 Holdings %
Top 10 Hldgs %
66.29%
Holding
201
New
72
Increased
18
Reduced
27
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$7.93M |
| 2 |
FNB Corp
FNB
|
+$7.61M |
| 3 |
Sherwin-Williams
SHW
|
+$7.06M |
| 4 |
Allstate
ALL
|
+$5.58M |
| 5 |
Willis Towers Watson
WTW
|
+$5.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$274M |
| 2 |
Celanese
CE
|
+$6.41M |
| 3 |
MON
Monsanto Co
MON
|
+$6.27M |
| 4 |
Bunge Global
BG
|
+$5.97M |
| 5 |
Air Products & Chemicals
APD
|
+$4.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.98% |
| 2 | Industrials | 5.93% |
| 3 | Healthcare | 5.67% |
| 4 | Technology | 4.78% |
| 5 | Communication Services | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $419M | 58.3% |
9,348,799
-8,033,393
| -46% | -$274M |
|
|
2
FNB Corp
FNB
$6.73B
| $8.22M | 1.14% |
586,000
+570,000
| +3,563% | +$7.61M |
|
|
3
Travelers Companies
TRV
$78.1B
| $7.78M | 1.08% |
+63,503
| New | +$7.93M |
|
|
4
Sherwin-Williams
SHW
$82.7B
| $7.34M | 1.02% |
+61,500
| New | +$7.06M |
|
|
5
Willis Towers Watson
WTW
$31.7B
| $7.28M | 1.01% |
47,216
+37,299
| +376% | +$5.57M |
|
|
6
Allstate
ALL
$68B
| $5.64M | 0.78% |
+61,349
| New | +$5.58M |
|
|
WCN
7
Waste Connections
WCN
$42.2B
| $5.6M | 0.78% |
80,000
+2,500
| +3% | +$165K |
|
8
Voya Financial
VOYA
$9.01B
| $5.57M | 0.77% |
+139,703
| New | +$5.35M |
|
9
Huntington Bancshares
HBAN
$34.4B
| $5.09M | 0.71% |
+365,000
| New | +$4.8M |
|
10
Honeywell
HON
$77B
| $4.96M | 0.69% |
38,745
-13,284
| -26% | -$1.65M |
|
11
Regions Financial
RF
$26.4B
| $4.95M | 0.69% |
325,000
-125,000
| -28% | -$1.8M |
|
12
Visa
V
$684B
| $4.91M | 0.68% |
46,639
+18,385
| +65% | +$1.86M |
|
|
PACW
13
DELISTED
PacWest Bancorp
PACW
| $4.85M | 0.67% |
96,000
+90,000
| +1,500% | +$4.21M |
|
|
GRA
14
DELISTED
W.R. Grace & Co.
GRA
| $4.69M | 0.65% |
+65,000
| New | +$4.59M |
|
15
FedEx
FDX
$72.7B
| $4.51M | 0.63% |
20,000
-500
| -2% | -$106K |
|
16
M&T Bank
MTB
$35.7B
| $4.51M | 0.63% |
+28,000
| New | +$4.4M |
|
|
DST
17
DELISTED
DST Systems Inc.
DST
| $4.3M | 0.6% |
+78,332
| New | +$4.29M |
|
18
Prosperity Bancshares
PB
$8.97B
| $4.27M | 0.59% |
65,000
| – | – |
|
|
STL
19
DELISTED
Sterling Bancorp
STL
| $4.19M | 0.58% |
170,000
-20,000
| -11% | -$456K |
|
20
Verisk Analytics
VRSK
$25.4B
| $4.01M | 0.56% |
48,244
-21,020
| -30% | -$1.74M |
|
21
GoDaddy
GDDY
$11B
| $3.98M | 0.55% |
+91,386
| New | +$3.94M |
|
22
Northern Trust
NTRS
$22.4B
| $3.92M | 0.55% |
+42,671
| New | +$3.85M |
|
23
Neurocrine Biosciences
NBIX
$16.8B
| $3.86M | 0.54% |
63,029
+18,371
| +41% | +$969K |
|
24
Hartford Financial Services
HIG
$38.9B
| $3.86M | 0.54% |
+69,571
| New | +$3.78M |
|
25
United Bankshares
UBSI
$6.63B
| $3.79M | 0.53% |
102,000
+40,000
| +65% | +$1.41M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q3 2017 Portfolio in Review
As of Q3 2017, Crestline Management held 201 positions worth $719M, down 3.6% from $746M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Crestline Management withdrew a net $214M in Q3 2017, closing 81 positions and reducing 27 holdings. Its most notable exit was Celanese, an estimated $6.41M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Crestline Management opened a new position in Travelers Companies worth $7.78M.
- Crestline Management's largest Q3 2017 buy was Travelers Companies: 63,503 shares worth $7.78M.
- Crestline Management added most to FNB Corp in Q3 2017, an estimated $7.61M increase.
- Crestline Management's biggest Q3 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $274M.
- Crestline Management fully exited Celanese in Q3 2017, selling an estimated $6.41M.
- Crestline Management's ten largest holdings make up 66% of its $719M portfolio in Q3 2017.
- Crestline Management opened 72 new positions and closed 81 in Q3 2017.
- Crestline Management's portfolio value fell 3.6% quarter-over-quarter to $719M.
Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.